The PLACORHEN study: a double-blind, placebo-controlled, randomized radionuclide study with 186Re-etidronate in hormone-resistant prostate cancer patients with painful bone metastases - Han, SH; de Klerk, JM; Tan, S (Placebo Controlled Rhenium Study. J Nucl Med, 2002)
et al.